Efficacy and safety of immune checkpoint inhibitors-combined antiangiogenic drugs in the treatment of hepatocellular carcinoma: A systematic review and meta analysisYu Zhong, Li Su, Shuqi Dai et al.|Frontiers in Oncology|2022Cited by 15
Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal CancerZehua Wu, Yanhong Deng, Yi Cheng et al.|Cancers|2023Cited by 6